Cargando…

678 Ceftaroline vs Vancomycin in Treatment for Skin and Soft Tissue Infections (SSTI) in Obese Patients

Detalles Bibliográficos
Autores principales:	Nguyen, Hao, Shah, Kaushal, Dhillon, Manjit, Gooch, Michael, Cook, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781785/ http://dx.doi.org/10.1093/ofid/ofu052.386

Ejemplares similares

165 Integrating a Rapid Diagnostic Test and Antimicrobial Stewardship: Optimizing Discharge Antibiotics in Skin and Soft Tissue Infections (SSTI)
por: Yu, Diana, et al.
Publicado: (2014)

474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
por: Pettit, Natasha, et al.
Publicado: (2014)

679 Ceftaroline Fosamil (CPT-F) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients
por: Kaye, Keith, et al.
Publicado: (2014)

722 Infectious Diseases Consultation Increases Adherence with Quality of Care Indicators for Management of Staphylococcus aureus Bacteremia
por: Dhillon, Manjit, et al.
Publicado: (2014)

472 Ceftaroline-induced Neutropenia: Two Case Reports
por: Martin, Kelly E., et al.
Publicado: (2014)

830 Reduction in Acute Gastrointestinal Infection among Military Trainees: Secondary Effects of a Hygiene-based Cluster-Randomized Trial for SSTI Prevention
por: D'onofrio, Michael, et al.
Publicado: (2014)

266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

731 Utility of Ceftaroline in the Treatment of Persistent Bacteremia and Deep-Seated Infections
por: Burgess, Donna R., et al.
Publicado: (2014)

393 Vancomycin Dosing in Obese Patients
por: Alquwaizani, Mohammed, et al.
Publicado: (2014)

809 Contemporary Experience with Ceftaroline Fosamil for the Treatment of Community-acquired Bacterial Pneumonia
por: Johnson, Leonard B, et al.
Publicado: (2014)

1652 Retrospective Comparision of Oral Vancomycin Capsules vs Oral Vancomycin Solution for the Treatment of Severe Clostridium Defficile Infection
por: Saleh, Rania, et al.
Publicado: (2014)

675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

673 Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation
por: Moise, Pamela, et al.
Publicado: (2014)

192 Vancomycin Dosing in Obese and Morbidly Obese Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia
por: Morrill, Haley, et al.
Publicado: (2014)

811 Antimicrobial activity of ceftaroline tested against respiratory tract infection (RTI) pathogens isolated from USA medical centers in 2013
por: Sader, Helio S., et al.
Publicado: (2014)

288 Lack of Synergy With Six Blood Isolates of Methicillin-Resistant Staphylococcus aureus (Vancomycin MIC of 2) Tested With Combinations of Vancomycin + Gentamicin, Vancomycin + Rifampin and Vancomycin + Cefazolin.
por: Long, Virginia, et al.
Publicado: (2014)

729 Activity of Ceftaroline and Comparator Agents Tested against Staphylococcus aureus from Patients with Bacteremia in United States (USA) Medical Centers (2009-2013)
por: Sader, Helio S., et al.
Publicado: (2014)

1651 Role of Metronidazole vs Vancomycin as Initial Therapy in Hospitalized Patients with Mild to Moderate Clostridium difficile Infection (CDI) with NAP1 vs non-NAP1 Disease
por: Dubrovskaya, Yanina, et al.
Publicado: (2014)

799 Linezolid vs Vancomycin in the Treatment of Nosocomial Pneumonia: A Cost-effectiveness Analysis Incorporating Results from the ZEPHyR Trial
por: Collins, Curtis, et al.
Publicado: (2014)

1331 The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
por: Corey, Ralph, et al.
Publicado: (2014)

396 What is the Best Predictor for Vancomycin Nephrotoxicity?
por: Hammoud, Kassem, et al.
Publicado: (2014)

728 Evaluation of Empirical Regimens Including Antistaphylococal Beta-lactam Antibiotics vs Vancomycin Monotherapy on Outcomes of Patients with Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia
por: Terico, Adrienne, et al.
Publicado: (2014)

282 Epidemiology of Skin and Soft-Tissue Infections in US Army Trainees at Fort Benning
por: Ellis, Michael, et al.
Publicado: (2014)

151 Is Nursing Home Specific Antibiogram Necessary for All Nursing Homes?
por: Shah, Kaushal, et al.
Publicado: (2014)

394 Influence of febrile neutropenia on the pharmacokinetics and dosage requirements of vancomycin
por: Shiotsuka, Shouichi, et al.
Publicado: (2014)

733 Vancomycin-Resistant Enterococcus (VRE) faecium Bloodstream Infections and Mortality
por: Suleyman, Geehan, et al.
Publicado: (2014)

688 The Effect of Preoperative Vancomycin on Bacteria Isolation from Operative Cultures
por: Young, Heather, et al.
Publicado: (2014)

721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
por: Khatib, Riad, et al.
Publicado: (2014)

392 Vancomycin Dosing and Concentrations at a Large University-Affiliated County Hospital
por: Youn, Gilmer, et al.
Publicado: (2014)

321 Screening Strategy to Detect Vancomycin-Resistant Enterococci Conversion in Exposed Roommates
por: Ng, Wil, et al.
Publicado: (2014)

409 Efficacy of Vancomycin against Biofilms of Neonatal Staphylococcus epidermidis Bloodstream Isolates
por: Simitsopoulou, Maria, et al.
Publicado: (2014)

1045 Linezolid Compared to Daptomycin for the Treatment of Vancomycin-resistant Enterococcal Urinary Tract Infections
por: Moenster, Ryan P., et al.
Publicado: (2014)

322 Vancomycin-resistant Enterococci with Reduced Daptomycin Susceptibility in Singapore: Prevalence and Associated Factor
por: Chow, Angela, et al.
Publicado: (2014)

148 Use of a Skin and Soft Tissue Protocol to Reduce Emergency Department use of Ertapenem in a 325 Bed Community Hospital
por: Waters, Dustin, et al.
Publicado: (2014)

281 Regional Changes in Methicillin-Resistant Staphylococcus aureus in Purulent Skin and Soft Tissue Infections among Patients Presenting to Canadian Emergency Departments
por: Ng, Wil, et al.
Publicado: (2014)

284 Risk Factors for Methicillin Resistant Staphylococcus aureus Skin and Soft Tissue Infections in Patients Found to be Colonized When Admitted to an Acute Care Hospital
por: Richardson, Andrea, et al.
Publicado: (2014)

1328 Decreased Vancomycin Use after Implementation of a Decision Support Program for Antibiotic Time Outs
por: Jones, Makoto, et al.
Publicado: (2014)

833 Lactobacillus GG (LGG) Does Not Eliminate Colonization by Vancomycin Resistant Enterococcus (VRE) in Adults with Comorbidities
por: Doron, Shira, et al.
Publicado: (2014)

476 Heterogeneous Vancomycin-Intermediate Coagulase-Negative Staphylococci in Neonates: Does treatment with Linezolid improve outcomes?
por: Blanchard, Ana Chelène, et al.
Publicado: (2014)

236 Taking an Antibiotic Timeout: Utilizing an Antibiotic Renewal Template for Automatic Approval of Vancomycin and Piperacillin-tazobactam
por: Graber, Christopher J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ricbulijqj0321g6dcbu4sklc8